Grygiel Nancy A. 4
4 · AMGEN INC · Filed Aug 22, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Grygiel Nancy A.
SVP & CCO
Transactions
- Sale
Common Stock
2025-08-20$296.99/sh−1,267$376,280→ 7,209 total
Holdings
- 103.808(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]These shares include 80 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F2]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.